Fundraising Fox

Mike Pellini

Investor

Managing Partner at S32

California

Writes $10K – $50K checks · typically $25K

About

General Partner of S32 (since 2017) and former CEO of Foundation Medicine through Roche's 2018 acquisition. Previously President and COO of Clarient. Holds an MD and focuses on personalized medicine and oncology.

Experience

  1. Section 32Managing Partnercurrent2017 — presentCa
  2. Foundation Medicine, Inc.Chairman2017 — 2018
  3. Foundation Medicine, Inc.CEO2011 — 2017
  4. Clarient, Inc.President and COO2007 — 2011

Education

  1. Thomas Jefferson University1993 — 1997
  2. Drexel University's LeBow College of BusinessMaster of Business Administration - MBA, Finance
  3. Boston CollegeBachelor’s Degree, Economics1983 — 1987
  4. Drexel University's LeBow College of BusinessMBA

Same school

Shared employers

Deals · 3

MedcryptBoard seat

via S32 · filed Feb 2025 · $8.7M raise

Twinstrand BiosciencesBoard seat

via S32 · filed Jun 2023 · $25.7M raise

Alpha SourceBoard seat

via S32 · filed Oct 2018 · $41.5M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at S32

Network4

Investors connected to Mike in public investor directories — a warm-intro map.